Drugs for Dwarfism (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 188)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Anastrozole |
Approved, Investigational |
Phase 4,Phase 3,Phase 2,Not Applicable |
|
120511-73-1 |
2187
|
Synonyms:
.alpha.,alpha.,.alpha.',.alpha.'-tetramethyl-5(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
1,3-benzenediacetonitrile, a, a, a', a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)
120511-73-1
2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)
2,2'-(5-(1H-1,2,4-Triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)
2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile)
2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)
2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile
a,a,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
AC1L1D49
AC-4234
alpha,alpha,alpha',alpha'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
anastrazole
Anastrazole
Anastrole
Anastrozol
anastrozole
Anastrozole (JAN/USAN/INN)
Anastrozole [USAN:INN:BAN]
Arimidex
Arimidex (TN)
Arimidex (Zeneca)
Arimidex, Anastrozole
Asiolex
Astra brand of anastrozole
Astra brand OF anastrozole
AstraZeneca brand of anastrozole
AstraZeneca brand OF anastrozole
C08159
C090450
C17H19N5
|
CHEBI:2704
CHEMBL1399
CID2187
CPD000466301
D00960
DB01217
HMS2052M11
HMS2089N10
HSDB 7462
I06-0021
ICI D1033
ICI-D 1033
ICI-D1033
LS-29563
MLS000759396
MLS001424217
MolPort-005-933-078
NCGC00164619-01
NSC719344
S1188_Selleck
SAM001246525
SBB066057
SMR000466301
UNII-2Z07MYW1AZ
ZD 1033
ZD1033
ZD-1033
Zeneca brand of anastrozole
Zeneca brand OF anastrozole
Zeneca ZD 1033
ZINC00000941
α,α,alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
|
|
2 |
|
Letrozole |
Approved, Investigational |
Phase 4,Phase 3 |
|
112809-51-5 |
3902
|
Synonyms:
1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole
1-[Bis-(4-cyanophenyl)methyl]-1,2,4-triazole
112809-51-5
4,4'-((1h-1,2,4-triazol-1-yl)methylene)dibenzonitrile
4,4'-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile
4,4'-(1h-1,2,4-triazol-1-ylmethylene) bis-benzonitrile
4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile)
4,4'-(1H-1,2,4-Triazol-1-yl-methylene)-bis(benzonitrile)
4,4'-(1h-1,2,4-triazol-1-ylmethylene)bisbenzonitrile
4,4'-(1h-1,2,4-triazol-1-ylmethylene)bis-benzonitrile
4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-Benzonitrile Letrozole
4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile
4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile
AB00514009
AC-1193
AC1L1GYT
AKOS005145822
BIDD:GT0015
BIDD:PXR0130
Bio-0057
BPBio1_001331
BRD-K88789588-001-03-2
BSPBio_001209
C067431
C08163
C17H11N5
CAS-112809-51-5
CCRIS 8822
CGS 20267
CGS 20267, Femara, Piroxicam, Letrozole
CGS-20267
CHEBI:6413
CHEMBL1444
CID3902
CPD000466343
D00964
DB01006
|
FEM-345
Femara
Fémara
Femara (TN)
Femera
HMS1571M11
HMS2051E08
HMS2089L22
HSDB 7461
I06-0022
Letoval
Letrozol
letrozole
Letrozole (JAN/USP/INN)
Letrozole [USAN:INN]
LS-38788
MLS000759455
MLS001424038
MLS002584991
MolPort-003-848-373
NCGC00016973-01
NCGC00016973-02
Novartis brand OF letrozole
Novartis Brand of Letrozole
NSC719345
Prestwick0_001025
Prestwick1_001025
Prestwick2_001025
Prestwick3_001025
S1235_Selleck
SAM001246649
SMR000466343
SPBio_003070
TL8000371
UNII-7LKK855W8I
ZINC03778874
|
|
3 |
|
Mecasermin |
Approved, Investigational |
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
68562-41-4 |
|
Synonyms:
IGF1
IGF-1
Insulin-like growth factor 1
Mecasermin recombinant
|
Mecasermin rinfabate
Mecasermin rinfabate recombinant
Mechano growth factor
Somatomedin-C
|
|
4 |
|
Deslorelin |
Investigational, Vet_approved |
Phase 4,Phase 2 |
|
57773-65-6 |
|
5 |
|
Hormone Antagonists |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
6 |
|
Hormones, Hormone Substitutes, and Hormone Antagonists |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
7 |
|
Hormones |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
8 |
|
Imatinib Mesylate |
|
Phase 4 |
|
220127-57-1 |
123596
|
9 |
|
Insulin, Globin Zinc |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
10 |
|
Mitogens |
|
Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1,Not Applicable |
|
|
|
11 |
|
insulin |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
12 |
|
Estrogen Receptor Antagonists |
|
Phase 4,Phase 3,Phase 2,Not Applicable |
|
|
|
13 |
|
Estrogen Antagonists |
|
Phase 4,Phase 3,Phase 2,Not Applicable |
|
|
|
14 |
|
Steroid Synthesis Inhibitors |
|
Phase 4,Phase 3,Phase 2,Not Applicable |
|
|
|
15 |
|
Antineoplastic Agents, Hormonal |
|
Phase 4,Phase 3,Phase 2,Not Applicable |
|
|
|
16 |
|
Estrogens |
|
Phase 4,Phase 3,Phase 2,Not Applicable |
|
|
|
17 |
|
Aromatase Inhibitors |
|
Phase 4,Phase 3,Phase 2,Not Applicable |
|
|
|
18 |
|
Pharmaceutical Solutions |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
19 |
|
Growth Hormone-Releasing Hormone |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
20 |
|
Contraceptive Agents |
|
Phase 4,Phase 3 |
|
|
|
21 |
|
Triptorelin Pamoate |
|
Phase 4 |
|
|
|
22 |
|
Luteolytic Agents |
|
Phase 4 |
|
|
|
23 |
|
Zinc |
Approved, Investigational |
Phase 2, Phase 3,Phase 3,Not Applicable,Early Phase 1 |
|
7440-66-6 |
|
Synonyms:
alpha D Mannosidase
alpha D Mannoside mannohydrolase
alpha Mannosidase
alpha Mannosidase b
alpha-D-Mannosidase
alpha-D-Mannoside mannohydrolase
alpha-Mannosidase
alpha-Mannosidase, lysosomal
alpha-Mannosidase, neutral
Dietary zinc
LAMAN
Lysosomal alpha mannosidase
Lysosomal alpha-mannosidase
Mannohydrolase, alpha-D-mannoside
|
Mannosidase b, alpha
Neutral alpha mannosidase
Neutral alpha-mannosidase
Topostin b
Zinc cation
ZINC ion
Zinc, chelated
Zinc, elemental
Zinc, ion (ZN2+)
Zincum metallicum
Zn
ZN(2+)
ZN(II)
ZN2+
|
|
24 |
|
Benzocaine |
Approved, Investigational |
Phase 2, Phase 3,Phase 3,Not Applicable |
|
94-09-7, 1994-09-7 |
2337
|
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-aminobenzoic acid ethyl ester
4-amino-benzoic acid ethyl ester
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
Acetate, benzocaine
Acetate, Benzocaine
AE-562/40377256
Aethoform
Aethylium paraminobenzoicum
AI3-02081
AKOS000119763
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
AR-1H9065
Baby anbesol
Baby Anbesol
BB_SC-0019
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
benzocaine
Benzocaine
Benzocaine (USP/INN)
Benzocaine [INN:BAN]
Benzocaine acetate
Benzocaine Acetate
Benzocaine formate
Benzocaine Formate
Benzocaine hydrobromide
Benzocaine Hydrobromide
Benzocaine hydrochloride
Benzocaine Hydrochloride
Benzocaine methanesulfonate
Benzocaine Methanesulfonate
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
C07527
CAS-94-09-7
Caswell No. 430A
CHEBI:116735
CHEMBL278172
Chloraseptic
CID2337
D001566
D00552
DB01086
Dermoplast
Diet ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl Aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
|
Ethyl PABA
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-Aminobenzoate
Ethyl P-aminobenzoate
Ethyl P-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-Aminophenylcarboxylate
Ethyl P-aminophenylcarboxylate
Ethyl P-aminophenylcarboxylic acid
ethylaminobenzoate-4
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny P-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
ETHYL-P-AMINOBENZOATE
Formate, benzocaine
Formate, Benzocaine
h-4-abz-oet
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, benzocaine
Hydrobromide, Benzocaine
Hydrochloride, benzocaine
Hydrochloride, Benzocaine
I05-0204
Identhesin
IDI1_000932
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
Methanesulfonate, benzocaine
Methanesulfonate, Benzocaine
MLS001331704
MLS002153970
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
nchembio.182-comp4
NINDS_000932
Norcain
Norcaine
Norcainum
NSC 122792
NSC 41531
NSC41531
NSC4688
Oprea1_750694
Oprea1_827402
Orabase-b
Ora-jel
Orthesin
Otocain
Outgro
p-(Ethoxycarbonyl)aniline
P-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
P-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
Parathesin
Parathesin (TN)
Parathesine
p-Carbethoxyaniline
P-Carbethoxyaniline
p-Ethoxycarboxylic aniline
p-Ethoxycarboxylic Aniline
P-Ethoxycarboxylic aniline
Prestwick_991
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Slim mint gum
SMR000059025
Solarcaine
Solu H
SPBio_000134
SPBio_002844
Spectrum_000074
SPECTRUM1500139
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
STK043620
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
|
|
25 |
|
tannic acid |
Approved |
Phase 2, Phase 3,Phase 3,Not Applicable |
|
|
|
26 |
|
Clonidine |
Approved |
Phase 3 |
|
4205-90-7 |
2803
|
Synonyms:
1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro- (9CI)
2-((2,6-Dichlorophenyl)imino)imidazolidine
2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2)
2-(2,6-Dichloroanilino)-2-imidazoline
2-(2,6-Dichlorophenylamino)-2-imidazoline
2-(2,6-Dichlorophenylimino)imidazolidine
2,6-dichloro-N-(2-imidazolidinylidene)aniline
2,6-dichloro-N-2-imidazolidinylidenebenzenamide
2,6-dichloro-N-2-Imidazolidinylidenebenzenamine
2,6-Dichloro-N-2-imidazolidinylidenebenzenamine
2,6-dichloro-N-imidazolidin-2-ylideneaniline
2-[(2,6-dichlorophenyl)imino]-2-imidazoline
2-[(2,6-Dichlorophenyl)imino]imidazoline
2-Imidazoline, 2-(2,6-dichloroanilino)- (7CI,8CI)
4205-90-7
4205-91-8 (mono-hydrochloride)
57066-25-8
734571A
AB00514634
AC1L1EI5
AC1Q3K6V
Adesipress
AKOS001595470
BIDD:GT0547
Bio1_000470
Bio1_000959
Bio1_001448
Bio2_000308
Bio2_000788
Boehringer ingelheim brand OF clonidine hydrochloride
BPBio1_000040
BRD-K98530306-001-02-1
BRD-K98530306-003-05-0
BSPBio_000036
BSPBio_001588
BSPBio_002055
C9H9Cl2N3
CAS-4205-91-8
Catapres
Catapres- TTS
Catapresan
Catapressan
Catapres-TTS
CATAPRES-TTS-1
CATAPRES-TTS-2
CATAPRES-TTS-3
Catarpres
Catarpresan
Catarpres-TTS
Catarpres-TTS (TN)
CCRIS 7787
CHEBI:3757
CHEBI:46632
CHEMBL134
Chlofazoline
Chlophazolin
Chlornidinum
CID2803
Clofelin
Clofenil
Clonidin
Clonidina
Clonidina [INN-Spanish]
clonidine
Clonidine (JAN/USAN/INN)
Clonidine [USAN:BAN:INN]
Clonidine dihydrochloride
Clonidine HCl
Clonidine hydrochloride
Clonidine monohydrobromide
Clonidine monohydrochloride
Clonidinhydrochlorid
Clonidinum
Clonidinum [INN-Latin]
Clonistada
Clopheline
D00281
DB00575
|
DB07566
Dihydrochloride, clonidine
DivK1c_000774
Dixarit
Duraclon
Duraclont
EINECS 224-119-4
Gemiton
Hemiton
HMS1361P10
HMS1791P10
HMS1989P10
HMS2089G11
HSDB 3040
Hydrochloride, clonidine
IDI1_000774
IDI1_034058
Ipotensium
Isoglaucon
KBio1_000774
KBio2_000308
KBio2_001821
KBio2_002876
KBio2_004389
KBio2_005444
KBio2_006957
KBio3_000615
KBio3_000616
KBio3_001275
KBioGR_000308
KBioGR_001572
KBioSS_000308
KBioSS_001821
Klofelin
Klofenil
L000193
Lopac0_000268
Lopac-C-7897
LS-79606
M 5041T
M-5041T
MolPort-001-779-668
MolPort-005-932-374
Monohydrobromide, clonidine
Monohydrochloride, clonidine
N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine
NCGC00015268-01
NCGC00015268-02
NCGC00015268-08
NCGC00024734-01
NCGC00024734-02
NCGC00024734-03
NCGC00024734-04
NCGC00024734-05
NCGC00179680-01
nchembio.79-comp11
nchembio705-10
NINDS_000774
Prestwick0_000248
Prestwick1_000248
Prestwick2_000248
Prestwick3_000248
SKF 34427
SPBio_001233
SPBio_002255
Spectrum_001341
Spectrum2_001187
Spectrum3_000358
Spectrum4_000956
Spectrum5_000759
ST 155BS
ST-155BS
ST-155-BS
T171
Tenso-Timelets
Tocris-0690
UNII-MN3L5RMN02
ZINC00896484
|
|
27 |
|
Medroxyprogesterone acetate |
Approved, Investigational |
Phase 3 |
|
71-58-9 |
|
Synonyms:
(6α)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione
17-Acetoxy-6α-methylprogesterone
17α-hydroxy-6α-methylprogesterone acetate
6-alpha-Methyl-17-alpha-acetoxyprogesterone
6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate
6α-Methyl-17-acetoxy progesterone
6α-Methyl-17α-hydroxyprogesterone acetate
|
6α-Methyl-4-pregnene-3,20-dion-17α-ol acetate
Medroxyacetate progesterone
Medroxyprogesterone 17-acetate
Methylacetoxyprogesterone
Metigestrona
MPA
|
|
28 |
|
Estradiol |
Approved, Investigational, Vet_approved |
Phase 3 |
|
50-28-2 |
5757
|
Synonyms:
(+)-3,17b-Estradiol
(17b)-Estra-1,3,5(10)-triene-3,17-diol
(17beta)-Estra-1,3,5(10)-triene-3,17-diol
(17β)-estra-1,3,5(10)-triene-3,17-diol
.alpha.-Estradiol
.alpha.-Oestradiol
.beta.-Estradiol
.beta.-Oestradiol
[2,4,6,7-3H]-E2
[3H]]estradiol
[3H]-estradiol
13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol
17 beta Estradiol
17 beta Oestradiol
17 beta-Estradiol
17 beta-Oestradiol
17.beta.-Estradiol
17-.BETA.-Estradiol
17.beta.-Oestradiol
17b Oestradiol
17b-Estra-1,3,5(10)-triene-3,17-diol
17b-Estradiol
17-beta
17beta oestradiol
17beta Oestradiol
17beta-Estra-1,3,5(10)-triene-3,17-diol
17-beta-estradiol
17beta-Estradiol
17beta-Oestradiol
17-beta-OH-estradiol
17b-Oestradiol
17E
17-E
17β oestradiol
17β-estra-1,3,5(10)-triene-3,17-diol
17β-estradiol
17β-oestradiol
1jgl
1qkt
1qku
2d06
3,17.beta.-Estradiol
3,17b-Dihydroxyestra-1,3,5(10)-triene
3,17b-Estradiol
3,17beta-Estradiol
3,17-beta-Estradiol
3,17-beta-Oestradiol
3,17-Epidihydroxyestratriene
50-28-2
73459-61-7
873662-39-6
AC-10460
AC1L1L2K
Aerodiol
Agofollin
Alora
Altrad
Amnestrogen
Aquadiol
Bardiol
b-Estradiol
B-Estradiol
beta-Estradiol
Beta-estradiol
BIDD:ER0125
BIDD:PXR0065
Bio-0812
Bio1_000403
Bio1_000892
Bio1_001381
Bio2_000363
Bio2_000843
Bio-E-Gel
bmse000642
BPBio1_000532
BSPBio_000482
BSPBio_001065
C00951
C18H24O2
CCRIS 280
CHEBI:16469
CHEMBL135
CID5757
cis-Estradiol
cis-Oestradiol
Climaderm
Climara
Climara (TN)
Climara Forte
cMAP_000005
CMC_11154
component of Menrium
Compudose
Compudose 200
Compudose 365
Corpagen
CPD000059126
CPD-352
D00105
D-3,17beta-Estradiol
DB00783
delta-Estradiol
delta-Oestradiol
Dermestril
Destradiol
D-Estradiol
Dihydrofollicular hormone
Dihydrofolliculin
Dihydromenformon
dihydro-Theelin
Dihydrotheelin
Dihydroxyesterin
Dihydroxyestrin
Dihydroxyoestrin
Dimenformon
Diogyn
Diogynets
Divigel
Divigel (TN)
D-Oestradiol
E 2
E 8875
E(sub 2)
E0025
E1024_SIGMA
E1132_SIGMA
E2257_SIGMA
E2758_SIGMA
E8875_SIGMA
EINECS 200-023-8
Elestrin
Encore
Epiestriol 50
Esclim
Estra-1,3,5(10)-triene-3,17b-diol
Estrace
Estrace (TN)
Estraderm
Estraderm (TN)
Estraderm MX
Estraderm TTS
Estraderm TTS 100
Estraderm TTS 50
estradiol
Estradiol
Estradiol [USAN:INN]
Estradiol 17 alpha
Estradiol 17 beta
Estradiol 17beta
Estradiol anhydrous
Estradiol hemihydrate
Estradiol hemihydrate, (17 alpha)-isomer
Estradiol monohydrate
Estradiol orion brand
Estradiol, (-)-isomer
Estradiol, (+-)-isomer
Estradiol, (16 alpha,17 alpha)-isomer
Estradiol, (16 alpha,17 beta)-isomer
Estradiol, (17-alpha)-isomer
Estradiol, (8 alpha,17 beta)-(+-)-isomer
Estradiol, (8 alpha,17 beta)-isomer
Estradiol, (9 beta,17 alpha)-isomer
Estradiol, (9 beta,17 beta)-isomer
Estradiol, monosodium salt
Estradiol, sodium salt
Estradiol-17 alpha
Estradiol-17 beta
Estradiol-17.beta.
Estradiol-17b
|
estradiol-17beta
Estradiol-17beta
Estradiol-17-beta
Estradiol-17β
Estradiol-3,17beta
Estradiolo
Estradiolo [DCIT]
Estradiolum
Estradiolum [INN]
Estradot
Estraldine
Estrapak 50
Estrasorb
Estrasorb (TN)
Estreva
Estrifam
Estring
Estring (TN)
Estring vaginal ring
Estroclim
Estroclim 50
Estrodiolum
Estrofem 2
Estrofem Forte
Estrogel
Estrogel (TN)
Estrogel HBF
Estrovite
EU-0100503
Evamist
Evorel
Extrasorb
Femanest
Femestral
Femestrol
Femogen
Fempatch
Femtrace
Femtran
Follicyclin
Gelestra
Ginedisc
Ginosedol
Gynergon
Gynestrel
Gynodiol
Gynoestryl
GynPolar
HMS1362E07
HMS1569I04
HMS1792E07
HMS1990E07
HMS2051C17
HMS2090E18
HSDB 3589
IDI1_002118
Innofem
Innofem (TN)
KBio2_000405
KBio2_002269
KBio2_002973
KBio2_004837
KBio2_005541
KBio2_007405
KBio3_000769
KBio3_000770
KBio3_002749
KBioGR_000405
KBioGR_002269
KBioSS_000405
KBioSS_002270
Lamdiol
LMST02010001
Lopac0_000503
LS-137
Macrodiol
Macrol
Menest
Menorest
Microdiol
MLS000069494
MLS000758312
MLS001076331
MolPort-001-794-632
NCGC00091544-00
NCGC00091544-01
NCGC00091544-02
NCGC00091544-04
NCGC00091544-05
NCGC00091544-06
NCGC00091544-07
NCGC00091544-08
NCGC00091544-09
NCGC00091544-12
NCGC00179321-01
NCGC00179321-02
nchembio.168-comp3
nchembio.76-comp2
nchembio775-comp2
nchembio794-comp6
nchembio860-comp1
Nordicol
Novartis pharmaceuticals brand OF estradiol
NSC9895
NSC-9895
Oesclim
Oestergon
Oestra-1,3,5(10)-triene-3,17b-diol
Oestradiol
Oestradiol Berco
Oestradiol R
Oestradiol-17.beta.
Oestradiol-17beta
Oestradiol-17-beta
Oestradiolum
Oestrogel
Oestroglandol
Oestrogynal
Orion brand OF estradiol
Ovahormon
Ovasterol
Ovastevol
Ovociclina
Ovocyclin
Ovocycline
Ovocylin
Perlatanol
Polyestradiol
Prestwick_207
Prestwick0_000441
Prestwick1_000441
Prestwick2_000441
Prestwick3_000441
Primofol
Profoliol
Profoliol b
Profoliol B
progynon
Progynon
Progynon DH
Progynon-DH
S1709_Selleck
S-21400
SAM001247032
Sandrena 1
Sandrena Gel
Sisare Gel
SK-Estrogens
SL-1100
SMP1_000121
SMR000059126
SPBio_002421
Spectrum5_002055
Syndiol
Systen
Tradelia
Trial SAT
Trocosone
UNII-4TI98Z838E
Vagifem
Vagifem (TN)
Vivelle
Vivelle (TN)
VIVELLE-DOT
Zerella
Zesteem
Zesteen
Zumenon
β-estradiol
|
|
29 |
|
Polyestradiol phosphate |
Approved |
Phase 3 |
|
28014-46-2 |
|
Synonyms:
(17-beta)-Estra-1,3,5(10)-triene-3,17-diol polymer with phosphoric acid
Estradiol phosphate polymer
Fosfato de poliestradiol
Oestradiol phosphate polymer
|
Phosphate de polyestradiol
Poly(estradiol phosphate)
Polyestradioli phosphas
|
|
30 |
|
Ethinyl Estradiol |
Approved |
Phase 3 |
|
57-63-6 |
5991
|
Synonyms:
17 alpha-ethinyestradiol
17 alpha-Ethinylestradiol
17 alpha-Ethynylestradiol
17 alpha-Ethynyloestradiol
17.alpha.-Ethinyl-17.beta.-estradiol
17.alpha.-Ethinylestradiol
17.alpha.-Ethynyl-17.beta.-oestradiol
17.alpha.-Ethynylestradiol
17.alpha.-Ethynylestradiol-l7.beta.
17.alpha.-Ethynyloestradiol
17.alpha.-Ethynyloestradiol-17.beta.
17a-Ethinyl estradiol
17a-Ethinyl-17b-estradiol
17a-Ethinylestradiol
17a-Ethynyl-17b-oestradiol
17a-Ethynylestradiol
17a-Ethynylestradiol-L7b
17a-Ethynyloestradiol
17a-Ethynyloestradiol-17b
17alpha-Ethinyl estradiol
17-alpha-Ethinyl-17-beta-estradiol
17alpha-Ethinylestradiol
17alpha-Ethinylestradiol-17beta
17-alpha-ethynyl estradiol
17-alpha-Ethynyl-17-beta-oestradiol
17alpha-Ethynylestradiol
17-alpha-Ethynylestradiol
17-alpha-Ethynylestradiol-17-beta
17alpha-Ethynyloestradiol
17alpha-Ethynyloestradiol-17beta
17-ethinyl-3,17-estradiol
17-Ethinyl-3,17-estradiol
17-ethinyl-3,17-oestradiol
17-Ethinyl-3,17-oestradiol
17-ethinylestradiol
17-Ethinylestradiol
17-Ethynylestradiol
17-Ethynylestradiol ram
17-Ethynyloestradiol
17α-ethinyl estradiol
17α-ethynylestradiol
406932-93-2
46263_FLUKA
46263_RIEDEL
57-63-6
77538-56-8
AC1L1LK6
AC-2169
Aethinyloestradiolum
Aethinyoestradiol
Aethinyoestradiol [German]
AI3-52941
Alora
Amenoron
Amenorone
Anovlar
BIDD:ER0162
Bio-0610
BRN 2419975
C07534
CCRIS 286
Certostat
CHEBI:4903
Chee-O-gen
Chee-O-Gen
Chee-O-genf
Chee-O-Genf
CHEMBL691
CID5991
component of Demulen
component of Oracon
component of Ortrel
CPD000058319
Cyclosa
D004997
D00554
DB00977
Dicromil
Diognat-e
Diognat-E
Diogyn e
Diogyn E
Diogyn-e
Diogyn-E
Diprol
Dyloform
E4876_SIGMA
EE
EE(sub 2)
EE2
Effik brand OF ethinyl estradiol
Effik Brand of Ethinyl Estradiol
EINECS 200-342-2
EO
Ertonyl
Esclim
Esteed
Estigyn
Estinyl
Estinyl (TN)
Eston-e
Eston-E
Estopherol
Estoral
Estoral (Orion)
Estoral (VAN)
Estoral [Orion]
Estoral {[orion]}
Estorals
Estradiol, ethinyl
Estradiol, Ethinyl
Estradiol, ethynyl
Estradiol, Ethynyl
Estring
Estrogen
Ethidol
Ethinoral
Ethinyl E2
|
ethinyl estradiol
Ethinyl estradiol
Ethinyl estradiol (USP)
Ethinyl Estradiol [USP]
Ethinyl estradiol hemihydrate
Ethinyl Estradiol Hemihydrate
Ethinyl estradiol, (8 alpha)-isomer
Ethinyl Estradiol, (8 alpha)-Isomer
Ethinyl estradiol, (8 alpha,17 alpha)-isomer
Ethinyl estradiol, (8 alpha,9 beta,13 alpha,14 beta)-isomer
Ethinyl estradiol, (9 beta,17 alpha)-isomer
Ethinyl oestradiol effik
Ethinyl Oestradiol Effik
Ethinylestradiol
ETHINYLESTRADIOL
Ethinylestradiol (JP15/INN)
Ethinylestradiol [INN:BAN:JAN]
Ethinylestradiol jenapharm
Ethinylestradiol Jenapharm
Ethinylestradiolum
Ethinylestradiolum [INN-Latin]
Ethinylestriol
Ethinyloestradiol
Ethinyloestradiol [Steroidal oestrogens]
Ethinyl-oestradiol effik
Ethinyl-Oestradiol Effik
Ethinyl-oestranol
Ethy 11
Ethynyl estradiol
Ethynylestradiol
Ethynylestradiol, Ethinyl Estradiol
Ethynyloestradiol
Eticyclin
Eticyclol
Eticylol
Etinestrol
Etinestryl
Etinilestradiol
Etinilestradiol [INN-Spanish]
Etinilestradiolo
Etinilestradiolo [DCIT]
Etinoestryl
Etistradiol
Etivex
Feminone
Fempatch
Follicoral
Ginestrene
Gynodiol
Gynolett
Hemihydrate, ethinyl estradiol
Hemihydrate, Ethinyl Estradiol
HMS2051I19
HSDB 3587
Inestra
Innofem
Jenapharm brand OF ethinyl estradiol
Jenapharm Brand of Ethinyl Estradiol
Jenapharm, ethinylestradiol
Jenapharm, Ethinylestradiol
Kolpolyn
Linoral
LMST02010036
LS-231
Lynoral
Menolyn
Menostar
Microfollin
Microfollin forte
Microfollin Forte
MLS000028479
MLS000758274
MolPort-001-794-636
NCGC00091533-01
NCGC00091533-04
NCGC00091533-05
NCI60_000234
neo-Estrone
Neo-Estrone
Nogest-S
Novestrol
NSC10973
NSC-10973
Oradiol
Orestralyn
Orestrayln
Organon brand OF ethinyl estradiol
Organon Brand of Ethinyl Estradiol
Ortho-Cyclen
Ovex
OVULEN-21
OVULEN-28
Palonyl
Perovex
Primogyn
Primogyn C
Primogyn m
Primogyn M
Progynon C
Progynon m
Progynon M
Prosexol
PUBERTAL ETHINYL ESTRADIOL STUDY
S1625_Selleck
SAM001247008
Schering brand OF ethinyl estradiol
Schering Brand of Ethinyl Estradiol
Schering-plough brand OF ethinyl estradiol
SGCUT00127
SMR000058319
Spanestrin
Thiuram e
Thiuranide
to_000048
UNII-423D2T571U
Vagifem
WLN: L E5 B666TTT&J E1 FQ F1UU1 OQ
Ylestrol
|
|
31 |
|
Estradiol valerate |
Approved, Investigational, Vet_approved |
Phase 3 |
|
979-32-8 |
|
32 |
|
Nicotinamide |
Approved, Investigational |
Phase 2, Phase 3,Phase 3,Phase 1 |
|
98-92-0 |
936
|
Synonyms:
.beta.-Pyridinecarboxamide
11032-50-1
123574-63-0
1yc5
3 Pyridinecarboxamide
37321-14-5
3-Carbamoylpyridine
3-Pyridinecarboxamide
3-Pyridinecarboxylic acid amide
47865U_SUPELCO
55600-01-6
63748-44-7
72340_FLUKA
72340_SIGMA
72347_FLUKA
78731-47-2
98-92-0
A186B02E-6C70-4E54-9739-79398D439AAA
AC1L1ACZ
AC1Q4ZFV
AC-907/25014114
Acid amide
AI3-02906
Amid kyseliny nikotinove
Amid kyseliny nikotinove [Czech]
Amide PP
Aminicotin
Amixicotyn
Amnicotin
Astra brand OF niacinamide
Astra Brand of Niacinamide
Austrovit PP
b 3, Vitamin
B 3, Vitamin
b3, Vitamin
B3, Vitamin
BB_NC-2290
Benicot
beta-Pyridinecarboxamide
bmse000281
b-Pyridinecarboxamide
C00153
C6H6N2O
CCRIS 1901
CHEBI:17154
CHEMBL1140
CID936
CPD000058212
D00036
D009536
DB02701
DEA No. 1405
Delonin amide
Dipegyl
Dipigyl
EINECS 202-713-4
EINECS 234-265-0
Endobion
Enduramide
Factor pp
Factor PP
Hansamid
HMS2052M21
HMS2090B05
HMS2093H03
HSDB 1237
I02-1741
I02-2250
InChI=1/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9
Inovitan PP
Jenapharm brand OF niacinamide
Jenapharm Brand of Niacinamide
Jenapharm, Nicotinsaureamid
Jenapharm, nicotinsäureamid
LS-2051
m-(Aminocarbonyl)pyridine
Mediatric
Merck brand OF niacinamide
Merck Brand of Niacinamide
MLS000069714
MolMap_000061
MolPort-001-783-876
N0078
N0636_SIGMA
N2142_SIGMA
N3376_SIGMA
N5535_SIAL
NAM
Nandervit-N
NCGC00093354-03
NCGC00093354-04
nchembio.154-comp4
nchembio.73-comp6
Niacevit
Niacin
niacin - Vitamin B3
niacinamide
Niacinamide
Niacinamide (USP)
Niacinamide [USAN]
|
Niacinamide astra brand
Niacinamide Astra Brand
Niacinamide jenapharm brand
Niacinamide Jenapharm Brand
Niacinamide merck brand
Niacinamide Merck Brand
Niacinamide pharmagenix brand
Niacinamide Pharmagenix Brand
Niacinamide, Nicotinic acid amide, Nicotinamide
Niacotinamide
Niamide
Niavit PP
Nicamide
Nicamina
Nicamindon
Nicasir
Nicobion
Nicofort
Nicogen
Nicomidol
Nicosan 2
Nicosylamide
Nicota
Nicotamide
Nicotilamide
Nicotililamido
Nicotinamid
Nicotinamida
Nicotinamida [INN-Spanish]
nicotinamide
Nicotinamide
Nicotinamide (JP15/INN)
Nicotinamide (Niacinamide)
Nicotinamide, niacin, vitamin B3
Nicotinamide-carbonyl-14C
Nicotinamidum
Nicotinamidum [INN-Latin]
Nicotinate amide
Nicotine acid amide
Nicotine amide
Nicotinic acid amide
Nicotinic amide
Nicotinsaeureamid
Nicotinsaureamid
Nicotinsaureamid [German]
Nicotinsaureamid Jenapharm
Nicotinsäureamid jenapharm
Nicotol
Nicotylamide
Nicotylamidum
Nicovel
Nicovit
Nicovitina
Nicovitol
Nicozymin
Nictoamide
Nikasan
Nikazan
niko-Tamin
Niko-tamin
Nikotinamid
Nikotinsaeureamid
Nikotinsaeureamid [German]
Niocinamide
Niozymin
NSC 13128
NSC13128
NSC27452
Papulex
Pelmin
Pelmine
Pelonin amide
Pharmagenix brand OF niacinamide
Pharmagenix Brand of Niacinamide
PP-Faktor
Propamine a
pyridine-3-carboxamide
Pyridine-3-carboxylic acid amide
S1899_Selleck
SAM001246860
Savacotyl
SGCUT00176
SMR000058212
to_000073
UNII-25X51I8RD4
Vi-nicotyl
Vi-Nicotyl
Vi-noctyl
Vitamin B
Vitamin B (VAN)
Vitamin b 3
Vitamin B 3
Vitamin b3
Vitamin H1
vitamin PP
Vitamin PP
Witamina PP
WLN: T6NJ CVZ
ZINC00005878
β-pyridinecarboxamide
|
|
33 |
|
Gefitinib |
Approved, Investigational |
Phase 2, Phase 3 |
|
184475-35-2 |
123631
|
Synonyms:
184475-35-2
4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline
4-(3'-chloro-4'-fluoroanilino)-7-Methoxy-6-(3-morpholinopropoxy)quinazoline
4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline
6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine
AC-1556
AC1L3X0A
AKOS000280752
BCB03_000781
Bio-0046
C419708
CCRIS 9011
CHEBI:49668
CHEMBL939
CID123631
CU-00000000396-1
D01977
DB00317
DB07998
EC-000.2409
EN002708
FT-0081035
Gefitini
gefitinib
Gefitinib
Gefitinib (JAN/USAN/INN)
Gefitinib [USAN]
Gefitinib, Iressa, ZD1839
Gelfitinib
HMS2089B19
I01-1227
IRE
|
Iressa
Iressa (TN)
Iressa(TM)
Irressat
K00240
KBioSS_002241
Kinome_3321
Kinome_3322
LS-139916
MolPort-000-883-335
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide
N-(3-chloro-4-Fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine
N-(3-chloro-4-Fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine
NCGC00159455-02
NCGC00159455-03
nchembio.117-comp18
nchembio866-comp14
NSC715055
S1025_Selleck
STK621310
UNII-S65743JHBS
ZD 1839
ZD1839
ZD-1839
ZD-1839, Iressa, Gefitinib
ZINC19632614
|
|
34 |
|
Dehydroepiandrosterone |
Approved, Investigational, Nutraceutical |
Phase 3 |
|
53-43-0 |
5881
|
Synonyms:
(+)-Dehydroisoandrosterone
(3beta)-3-Hydroxy-androst-5-en-17-one
(3-beta)-3-Hydroxyandrost-5-en-17-one
(3beta,16alpha)-3,16-Dihydroxy-androst-5-en-17-one
17-Chetovis
17-Hormoforin
3-beta-hydroxy-5-androsten-17-one
3beta-Hydroxy-5-androsten-17-one
3-beta-Hydroxy-5-androsten-17-one
3beta-hydroxyandrost-5-en-17-one
3beta-Hydroxyandrost-5-en-17-one
3beta-Hydroxy-androst-5-en-17-one
3-beta-Hydroxyandrost-5-en-17-one
3beta-Hydroxy-D5-androsten-17-one
3b-Hydroxyandrost-5-en-17-one
3b-Hydroxy-D5-androsten-17-one
3β-hydroxyandrost-5-en-17-one
5,6-Dehydroisoandrosterone
5,6-Didehydroisoandrosterone
5-Androsten-3beta-ol-17-one
5-Androsten-3-beta-ol-17-one
5-Androsten-3b-ol-17-one
5-dehydro-Epiandrosterone
5-Dehydroepiandrosterone
|
Andrestenol
Androst-5-ene-3beta-ol-17-one
Androst-5-ene-3b-ol-17-one
Androsten-3beta-ol-17-one
Androstenolone
Astenile
D5-Androsten-3beta-ol-17-one
D5-Androsten-3b-ol-17-one
Deandros
Dehydroandrosterone
dehydro-Epi-androsterone
Dehydroepiandrosterone
Dehydroisoandrosterone
DHEA
Diandron
Diandrone
Hydroxyandrostenone
Prasterona
Prasterone
Prasteronum
Prestara
Psicosterone
trans-Dehydroandrosterone
|
|
35 |
|
Niacin |
Approved, Investigational, Nutraceutical |
Phase 2, Phase 3,Phase 3,Phase 1 |
|
59-67-6 |
938
|
Synonyms:
3 Pyridinecarboxylic acid
3-Carboxylpyridine
3-carboxypyridine
3-Carboxypyridine
3-Pyridinecarboxylate
3-Pyridinecarboxylic acid
3-Pyridylcarboxylate
3-Pyridylcarboxylic acid
Acide nicotinique
Acide Nicotinique
acido Nicotinico
Acido nicotinico
Acidum nicotinicum
Acidum Nicotinicum
Akotin
Aluminum salt, niacin
Anti-pellagra vitamin
Apelagrin
beta-Pyridinecarboxylate
beta-Pyridinecarboxylic acid
b-Pyridinecarboxylate
b-Pyridinecarboxylic acid
Daskil
Efacin
Enduracin
Hydrochloride, niacin
Induracin
Linic
Lithium nicotinate
m-Pyridinecarboxylate
m-Pyridinecarboxylic acid
M-Pyridinecarboxylic Acid
Niac
Niacin
Niacin aluminum salt
Niacin ammonium salt
Niacin calcium salt
Niacin cobalt (2+) salt
Niacin copper (2+) salt
Niacin hydrochloride
Niacin iron (2+) salt
Niacin lithium salt
Niacin lithium salt, hemihydrate
Niacin magnesium salt
Niacin manganese (2+) salt
Niacin potassium salt
Niacin sodium salt
Niacin tartrate
|
Niacin tosylate
Niacin zinc salt
Niacina
Niacine
Niacor
Nicacid
Nicamin
Nicangin
nico 400
nico-400
Nico400
Nicobid
Nicocap
Nicodelmine
Nicolar
Niconacid
Nicosan 3
nico-Span
Nicotinate
Nicotinate, lithium
Nicotinic Acid
Nicotinipca
Nicyl
Nikotinsaeure
Nyclin
P.P. factor
Pellagra preventive factor
Pellagrin
Pelonin
Potassium salt, niacin
PP Factor
Pyridine-b-carboxylate
Pyridine-b-carboxylic acid
Pyridine-beta-carboxylate
Pyridine-beta-carboxylic acid
Pyridine-β-carboxylate
pyridine-β-carboxylic acid
Pyridine-β-carboxylic acid
slo-Niacin
Sodium salt, niacin
Tartrate, niacin
Tosylate, niacin
Vitamin b3
Vitamin B3
Wampocap
β-pyridinecarboxylate
β-pyridinecarboxylic acid
|
|
36 |
|
Folic Acid |
Approved, Nutraceutical, Vet_approved |
Phase 2, Phase 3,Phase 1 |
|
59-30-3 |
6037
|
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
AI3-26387
AKOS000503224
Antianemia factor
Apo-Folic
ARONIS014410
b9, Vitamin
BIDD:ER0563
BIDD:GT0641
BIF0608
bmse000299
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat b activ
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
Facid
Factor U
FOL
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
|
Folsaeure
Folsan
Folsaure
Folsäure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
Incafolic
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
Liver lactobacillus casei factor
Liver Lactobacillus casei factor
LS-2157
Millafol
Mission prenatal
Mittafol
MLS001304016
MLS001335861
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-Pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
nchembio.108-comp10
Nifolin
Nifolin [Denmark]
NINDS_000494
Novofolacid
Novofolacid [Canada]
N-Pteroyl-L-glutamate
N-pteroyl-L-glutamic acid
N-Pteroyl-L-glutamic acid
NSC 3073
PGA
PGA (VAN)
Prestwick_230
Prestwick3_000627
PteGlu
Pteroylglutamate
Pteroylglutamic acid
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
Serum Folate Level
SMP2_000137
SMR000471860
SPBio_001357
Spectrum_001381
SPECTRUM1502020
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin b9
Vitamin B9
Vitamin Bc
Vitamin BC
Vitamin be
Vitamin Be
Vitamin m
Vitamin M
|
|
37 |
|
Hypoglycemic Agents |
|
Phase 2, Phase 3,Phase 3,Not Applicable,Early Phase 1 |
|
|
|
38 |
|
Trace Elements |
|
Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable |
|
|
|
39 |
|
Micronutrients |
|
Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable |
|
|
|
40 |
|
Chelating Agents |
|
Phase 2, Phase 3 |
|
|
|
41 |
|
DHEA (Dehydroepiandrosterone) |
|
Phase 3 |
|
|
|
42 |
|
Adjuvants, Immunologic |
|
Phase 3 |
|
|
|
43 |
|
Immunologic Factors |
|
Phase 3,Phase 2,Phase 1 |
|
|
|
44 |
|
arginine |
|
Phase 3,Not Applicable |
|
|
|
45 |
|
Analgesics |
|
Phase 3,Phase 2,Not Applicable |
|
|
|
46 |
|
Autonomic Agents |
|
Phase 3,Phase 2 |
|
|
|
47 |
|
Adrenergic alpha-Agonists |
|
Phase 3 |
|
|
|
48 |
|
Antihypertensive Agents |
|
Phase 3 |
|
|
|
49 |
|
Sympatholytics |
|
Phase 3 |
|
|
|
50 |
|
Adrenergic Agents |
|
Phase 3,Phase 2 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 364)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission |
Unknown status |
NCT01901666
|
Phase 4 |
Growth Hormone |
2 |
Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children |
Unknown status |
NCT02314676
|
Phase 4 |
|
3 |
Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency |
Unknown status |
NCT02908958
|
Phase 4 |
|
4 |
Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency |
Unknown status |
NCT02976675
|
Phase 4 |
|
5 |
Short Stature Related Distress |
Completed |
NCT01246219
|
Phase 4 |
GH treatment (Genotropin);1 year treatment with placebo followed by optional 3 years of GH treatment |
6 |
Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature |
Completed |
NCT00458263
|
Phase 4 |
Somatotropin growth hormone recombinant human |
7 |
Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen® |
Completed |
NCT01187550
|
Phase 4 |
Recombinant human growth hormone (r-hGH) |
8 |
A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood |
Completed |
NCT01157793
|
Phase 4 |
r-hGH;r-hGH |
9 |
Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years |
Completed |
NCT01066052
|
Phase 4 |
r-hGH |
10 |
Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA) |
Completed |
NCT01859949
|
Phase 4 |
Genotropin (somatropin) |
11 |
Growth Hormone and Endothelial Function in Children |
Completed |
NCT00373386
|
Phase 4 |
growth hormone |
12 |
Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation |
Completed |
NCT01734447
|
Phase 4 |
somatropin;somatropin;somatropin |
13 |
Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.) |
Completed |
NCT01605331
|
Phase 4 |
sustained-release recombinant human GH (SR-rhGH) |
14 |
Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients |
Completed |
NCT01562834
|
Phase 4 |
somatropin;placebo |
15 |
Easypod United States User Trial |
Completed |
NCT00689260
|
Phase 4 |
|
16 |
A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood |
Completed |
NCT00212758
|
Phase 4 |
Nutropin AQ |
17 |
A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency |
Completed |
NCT02311894
|
Phase 4 |
Somatropin |
18 |
An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD) |
Completed |
NCT01806298
|
Phase 4 |
Saizen® solution for injection (referred as Saizen®) |
19 |
Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency |
Completed |
NCT00490191
|
Phase 4 |
Somatropin |
20 |
Comparison of a Needle-free Injection Method With a Needle-syringe Injection Method |
Completed |
NCT00990340
|
Phase 4 |
|
21 |
Growth Hormone and Glucose Metabolism |
Completed |
NCT00929799
|
Phase 4 |
recombinant human Growth Hormone (Genotropin® ) |
22 |
Liquid Somatropin Formulation in Children With Growth Hormone Deficiency |
Completed |
NCT00567385
|
Phase 4 |
somatropin |
23 |
IGF1 Generation Test |
Completed |
NCT00145457
|
Phase 4 |
|
24 |
Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj. |
Completed |
NCT03015909
|
Phase 4 |
Somatropin |
25 |
Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia |
Completed |
NCT00140413
|
Phase 4 |
Nutropin AQ |
26 |
Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome? |
Completed |
NCT01298180
|
Phase 4 |
Growth hormone (Genotonorm® or Omnitrope®) |
27 |
GH and Cardiovascular Risk Factors |
Completed |
NCT01877512
|
Phase 4 |
Change in daily dosage of Growth Hormone |
28 |
First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study |
Completed |
NCT01419249
|
Phase 4 |
|
29 |
Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN® |
Completed |
NCT00256126
|
Phase 4 |
Saizen;Saizen |
30 |
Anterior Pituitary Hormone Replacement in Traumatic Brain Injury |
Completed |
NCT00957671
|
Phase 4 |
Recombinant human growth hormone |
31 |
Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents |
Completed |
NCT01245374
|
Phase 4 |
|
32 |
Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole |
Recruiting |
NCT02137538
|
Phase 4 |
Letrozole;Anastrozole |
33 |
Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children |
Recruiting |
NCT03290235
|
Phase 4 |
PEG-somatropin |
34 |
Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency |
Recruiting |
NCT03249480
|
Phase 4 |
|
35 |
Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I) |
Recruiting |
NCT02380235
|
Phase 4 |
|
36 |
Body Composition and Adipose Tissue in HIV |
Recruiting |
NCT03226821
|
Phase 4 |
Tesamorelin |
37 |
A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height |
Active, not recruiting |
NCT00840944
|
Phase 4 |
somatropin;triptorelin |
38 |
A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury |
Terminated |
NCT00638053
|
Phase 4 |
|
39 |
Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency |
Terminated |
NCT01698944
|
Phase 4 |
somatropin |
40 |
Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury |
Terminated |
NCT00555009
|
Phase 4 |
Genotropin;Placebo |
41 |
Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF) |
Withdrawn |
NCT01438801
|
Phase 4 |
Nutropin [Somatropin (rDNA origin) for injection] |
42 |
Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury. |
Withdrawn |
NCT00432263
|
Phase 4 |
Genotropin (PN-180,307) Somatropin |
43 |
Treatment of Children With Insufficient Secretion of Growth Hormone |
Unknown status |
NCT00271518
|
Phase 3 |
growth hormone (somatropin) |
44 |
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature |
Completed |
NCT00396097
|
Phase 3 |
Genotropin;Genotropin |
45 |
Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature |
Completed |
NCT01248416
|
Phase 3 |
Aromatase Inhibitor;Growth Hormone;Aromatase Inhibitor and Growth Hormone |
46 |
Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short Stature |
Completed |
NCT00355030
|
Phase 3 |
somatropin;leuprorelin |
47 |
A Phase 3 Study to Evaluate the Safety and Efficacy of Saizen® in Children With Idiopathic Short Stature (ISS) |
Completed |
NCT01746862
|
Phase 3 |
Saizen®;Saizen® |
48 |
Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature |
Completed |
NCT01778023
|
Phase 3 |
somatropin |
49 |
Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature |
Completed |
NCT01786902
|
Phase 3 |
DA-3002 |
50 |
Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome |
Completed |
NCT01927861
|
Phase 3 |
somatropin |
Inferred drug relations via
UMLS
73
/
NDF-RT
51
:
|